Pancreatic Cancer Research

ResearcherNantong UniversityActive in the last 2 years

Xiaorong Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8912-5066; OpenAlex author ID A5100630632. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. TNFRSF9 Inhibits Pancreatic Cancer Progression by Regulating PAX6-mediated Cell Proliferation, Migration, and Apoptosis. Co-author DOI 10.1097/mpa.0000000000002497↗
  2. NF45 overexpression is associated with poor prognosis and enhanced cell proliferation of pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s11010-015-2535-7↗
  3. High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC). Co-author DOI 10.1007/s13277-015-3625-6↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lingyu Hu · 1 shared paper, 2025 · strength 0.30
  2. Guoxiong Zhou · 2 shared papers, 2015 · strength 0.09
  3. Ji Li · 2 shared papers, 2015 · strength 0.09
  4. Chunhua Wan · 2 shared papers, 2015 · strength 0.09
  5. Gong Chen · 1 shared paper, 2015 · strength 0.05
  6. Haifeng Zhang · 1 shared paper, 2015 · strength 0.05
  7. Liang Wang · 1 shared paper, 2015 · strength 0.04
  8. Yixin Zhang · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.